O75475 (PSIP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 121.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: PC4 and SFRS1-interacting protein Alternative name(s): CLL-associated antigen KW-7 Dense fine speckles 70 kDa protein Short name=DFS 70 Lens epithelium-derived growth factor Transcriptional coactivator p75/p52 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 530 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration. Ref.9 |
| Subunit structure | Monomer. Interacts with IFRD1/PC4. Isoform 2 interacts with SFRS1. Isoform 1 interacts POGZ and CDCA7L. Isoform 1 interacts with lentiviral integrase and acts as a chromatin tethering factor to the chromosomal DNA. Isoform 1 interacts in particular with the human HIV-1 integrase protein (HIV-1 IN), determining its nuclear localization, its tight association with chromatin and its protection from the proteasome. Isoform 1 interacts also with HIV-2 IN. Isoform 2 does not interact with HIV-1 IN. Ref.1 Ref.10 Ref.11 Ref.12 Ref.13 Ref.20 Ref.25 |
| Subcellular location | Nucleus. Note: Remains chromatin-associated throughout the cell cycle. Ref.9 Ref.13 |
| Tissue specificity | Widely expressed. Expressed at high level in the thymus. Expressed in fetal and adult brain. Expressed in neurons, but not astrocytes. Markedly elevated in fetal as compared to adult brain. In the adult brain, expressed in the subventricular zone (SVZ), in hippocampus, and undetectable elsewhere. In the fetal brain, expressed in the germinal neuroepithelium and cortical plate regions. Ref.1 Ref.9 |
| Domain | Residues 340-417 are necessary and sufficient for the interaction with HIV-1 IN (IBD domain). |
| Involvement in disease | A chromosomal aberration involving PSIP1 is associated with pediatric acute myeloid leukemia (AML) with intermediate characteristics between M2-M3 French-American-British (FAB) subtypes. Translocation t(9;11)(p22;p15) with NUP98. The chimeric transcript is an in-frame fusion of NUP98 exon 8 to PSIP1/LEDGF exon 4. |
| Sequence similarities | Belongs to the HDGF family. Contains 1 PWWP domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O75475-1) Also known as: p75; PSIP1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Less active than isoform 2 as transcriptional coactivator, but more abundant in cells. | ||||||
| Isoform 2 (identifier: O75475-2) Also known as: p52; PSIP2; The sequence of this isoform differs from the canonical sequence as follows: 326-333: QQNKDEGK → HQTTCNLQ 334-530: Missing. | ||||||
| Isoform 3 (identifier: O75475-3) The sequence of this isoform differs from the canonical sequence as follows: 326-530: QQNKDEGKKP...ISLKDSTLDN → HFAL |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 530 | 530 | PC4 and SFRS1-interacting protein | PRO_0000191708 | ||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||
| Domain | 1 – 64 | 64 | PWWP | |||||||||||||||||||||||||||||||||||
| Coiled coil | 306 – 334 | 29 | Potential | |||||||||||||||||||||||||||||||||||
| Coiled coil | 371 – 395 | 25 | Potential | |||||||||||||||||||||||||||||||||||
| Motif | 146 – 156 | 11 | Nuclear localization signal Ref.12 | |||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 102 | 1 | Phosphoserine Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 106 | 1 | Phosphoserine Ref.18 Ref.22 Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 122 | 1 | Phosphothreonine Ref.15 Ref.22 | |||||||||||||||||||||||||||||||||||
| Modified residue | 129 | 1 | Phosphoserine Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 134 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||||||||||||
| Modified residue | 141 | 1 | Phosphothreonine Ref.18 Ref.21 Ref.22 Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 167 | 1 | Phosphothreonine Ref.21 | |||||||||||||||||||||||||||||||||||
| Modified residue | 177 | 1 | Phosphoserine Ref.21 Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 206 | 1 | Phosphoserine Ref.22 Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 273 | 1 | Phosphoserine Ref.18 Ref.21 Ref.22 | |||||||||||||||||||||||||||||||||||
| Modified residue | 275 | 1 | Phosphoserine Ref.18 Ref.21 Ref.22 Ref.24 | |||||||||||||||||||||||||||||||||||
| Modified residue | 434 | 1 | Phosphoserine Ref.18 Ref.22 | |||||||||||||||||||||||||||||||||||
| Modified residue | 437 | 1 | Phosphothreonine Ref.16 | |||||||||||||||||||||||||||||||||||
| Modified residue | 443 | 1 | Phosphoserine Ref.18 | |||||||||||||||||||||||||||||||||||
| Modified residue | 522 | 1 | Phosphoserine Ref.18 Ref.22 | |||||||||||||||||||||||||||||||||||
| Modified residue | 527 | 1 | Phosphothreonine Ref.18 Ref.22 Ref.24 | |||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 326 – 530 | 205 | QQNKD…STLDN → HFAL in isoform 3. | VSP_044435 | ||||||||||||||||||||||||||||||||||
| Alternative sequence | 326 – 333 | 8 | QQNKDEGK → HQTTCNLQ in isoform 2. | VSP_014297 | ||||||||||||||||||||||||||||||||||
| Alternative sequence | 334 – 530 | 197 | Missing in isoform 2. | VSP_014298 | ||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 360 | 1 | K → A: Reduced interaction with POGZ, CDCA7L and human HIV-1 integrase. Ref.20 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 365 | 1 | I → A: Loss of interaction with human HIV-1 integrase; reduced interaction with POGZ and CDCA7L. Ref.20 Ref.25 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 366 | 1 | D → A or N: Loss of interaction with human HIV-1 integrase; no effect on interaction with CDCA7L. Ref.20 Ref.25 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 366 | 1 | D → A: No effect on interaction with POGZ. Ref.20 Ref.25 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 370 | 1 | V → A: Reduced interaction with POGZ, CDCA7L and human HIV-1 integrase. Ref.20 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 406 | 1 | F → A: Loss of interaction with human HIV-1 integrase and POGZ; reduced interaction with CDCA7L. Ref.20 Ref.25 | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 408 | 1 | V → A: Reduced interaction with human HIV-1 integrase; no effect on interaction with POGZ and CDCA7L. Ref.20 Ref.25 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 153 – 161 | 9 | Missing in AAH64135. Ref.7 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 224 | 1 | E → G in AAC97946. Ref.1 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 224 | 1 | E → G in AAC97945. Ref.1 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 272 | 1 | T → P in AAB52589. Ref.8 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 420 | 1 | Y → F in AAC97946. Ref.1 | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 420 | 1 | Y → F in AAB52589. Ref.8 | |||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||
| Helix | 2 – 4 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 10 – 13 | 4 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 21 – 25 | 5 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 40 – 44 | 5 | ||||||||||||||||||||||||||||||||||||
| Turn | 45 – 47 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 50 – 53 | 4 | ||||||||||||||||||||||||||||||||||||
| Helix | 55 – 57 | 3 | ||||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 60 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 61 – 68 | 8 | ||||||||||||||||||||||||||||||||||||
| Helix | 77 – 86 | 10 | ||||||||||||||||||||||||||||||||||||
| Helix | 347 – 362 | 16 | ||||||||||||||||||||||||||||||||||||
| Helix | 365 – 367 | 3 | ||||||||||||||||||||||||||||||||||||
| Helix | 370 – 381 | 12 | ||||||||||||||||||||||||||||||||||||
| Helix | 387 – 391 | 5 | ||||||||||||||||||||||||||||||||||||
| Helix | 394 – 403 | 10 | ||||||||||||||||||||||||||||||||||||
| Helix | 410 – 425 | 16 | ||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation." Ge H., Si Y., Roeder R.G. EMBO J. 17:6723-6729(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 4-39 AND 76-89, TISSUE SPECIFICITY, INTERACTION WITH PC4. Tissue: Cervix carcinoma. |
| [2] | "Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts." Singh D.P., Ohguro N., Kikuchi T., Sueno T., Reddy V.N., Yuge K., Chylack L.T. Jr., Shinohara T. Biochem. Biophys. Res. Commun. 267:373-381(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Lens. |
| [3] | "Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing." Singh D.P., Kimura A., Chylack L.T. Jr., Shinohara T. Gene 242:265-273(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2). |
| [4] | "Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX." Krackhardt A.M., Witzens M., Harig S., Hodi F.S., Zauls A.J., Chessia M., Barrett P., Gribben J.G. Blood 100:2123-2131(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Leukemia. |
| [5] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3). Tissue: Testis and Uterus. |
| [8] | "Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions." Ochs R.L., Muro Y., Si Y., Ge H., Chan E.K.L., Tan E.M. J. Allergy Clin. Immunol. 105:1211-1220(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 180-530 (ISOFORM 1). |
| [9] | "Lens epithelium-derived growth factor (LEDGF/p75) expression in fetal and adult human brain." Chylack L.T. Jr., Fu L., Mancini R., Martin-Rehrmann M.D., Saunders A.J., Konopka G., Tian D., Hedley-Whyte E.T., Folkerth R.D., Goldstein L.E. Exp. Eye Res. 79:941-948(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [10] | "Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase." Llano M., Delgado S., Vanegas M., Poeschla E.M. J. Biol. Chem. 279:55570-55577(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUMAN HIV-1 INTEGRASE (ISOFORM 1). |
| [11] | "The interaction of LEDGF/p75 with integrase is lentiviral-specific and promotes DNA binding." Busschots K., Vercammen J., Emiliani S., Benarous R., Engelborghs Y., Christ F., Debyser Z. J. Biol. Chem. 280:17841-17847(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUMAN HIV-1 AND HIV-2 INTEGRASE (ISOFORM 1). |
| [12] | "Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering." Vanegas M., Llano M., Delgado S., Thompson D., Peretz M., Poeschla E.M. J. Cell Sci. 118:1733-1743(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUMAN HIV-1 INTEGRASE (ISOFORM 1), NUCLEAR LOCALIZATION SIGNAL. |
| [13] | "A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2." Ge H., Si Y., Wolffe A.P. Mol. Cell 2:751-759(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SFRS1, SUBCELLULAR LOCATION. |
| [14] | "t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia." Morerio C., Acquila M., Rosanda C., Rapella A., Tassano E., Micalizzi C., Panarello C. Leuk. Res. 29:467-470(2005) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH NUP98. |
| [15] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-437, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [17] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: T-cell. |
| [18] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; THR-141; SER-273; SER-275; SER-434; SER-443; SER-522 AND THR-527, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Liver. |
| [20] | "Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ." Bartholomeeusen K., Christ F., Hendrix J., Rain J.C., Emiliani S., Benarous R., Debyser Z., Gijsbers R., De Rijck J. J. Biol. Chem. 284:11467-11477(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH POGZ; HIV-1 INTEGRASE AND CDCA7L, MUTAGENESIS OF LYS-360; ILE-365; ASP-366; VAL-370; PHE-406 AND VAL-408. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-141; THR-167; SER-177; SER-273 AND SER-275, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [22] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; THR-122; THR-141; SER-206; SER-273; SER-275; SER-434; SER-522 AND THR-527, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [23] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [24] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-106; SER-129; THR-141; SER-177; SER-206; SER-275 AND THR-527, MASS SPECTROMETRY. |
| [25] | "Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75." Cherepanov P., Sun Z.-Y., Rahman S., Maertens G., Wagner G., Engelman A. Nat. Struct. Mol. Biol. 12:526-532(2005) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 347-471, SUBUNIT, MUTAGENESIS OF ILE-365; ASP-366; PHE-406 AND VAL-408. |
| [26] | "Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75." Cherepanov P., Ambrosio A.L.B., Rahman S., Ellenberger T., Engelman A. Proc. Natl. Acad. Sci. U.S.A. 102:17308-17313(2005) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 347-442 IN COMPLEX WITH HUMAN HIV-1 INTEGRASE. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF098483 mRNA. Translation: AAC97946.1. AF098482 mRNA. Translation: AAC97945.1. AF063020 mRNA. Translation: AAC25167.1. AF199339 Genomic DNA. Translation: AAF25870.1. AF199339 Genomic DNA. Translation: AAF25871.1. AF432220 mRNA. Translation: AAL99926.1. AL359998, AL441925, AL513423 Genomic DNA. Translation: CAH71355.1. AL441925, AL359998, AL513423 Genomic DNA. Translation: CAI13287.1. CH471071 Genomic DNA. Translation: EAW58677.1. CH471071 Genomic DNA. Translation: EAW58678.1. CH471071 Genomic DNA. Translation: EAW58679.1. BC044568 mRNA. Translation: AAH44568.2. BC064135 mRNA. Translation: AAH64135.1. U94319 mRNA. Translation: AAB52589.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00028122. IPI00333317. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PIR | JC7168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_001121689.1. NM_001128217.1. NP_066967.3. NM_021144.3. NP_150091.2. NM_033222.3. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.741408. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DIP | DIP-46656N. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IntAct | O75475. 8 interactions. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000370109. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allergome | 2120. Hom s DSF70. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PaxDb | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PeptideAtlas | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRIDE | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DNASU | 11168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000380715; ENSP00000370091; ENSG00000164985. ENST00000380716; ENSP00000370092; ENSG00000164985. ENST00000380733; ENSP00000370109; ENSG00000164985. ENST00000380738; ENSP00000370114; ENSG00000164985. ENST00000397519; ENSP00000380653; ENSG00000164985. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneID | 11168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:11168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc003zlv.4. human. uc003zly.3. human. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTD | 11168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC09M015456. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:9527. PSIP1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HPA | CAB013718. HPA019697. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MIM | 603620. gene. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA33872. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| eggNOG | NOG316844. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG108300. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InParanoid | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OMA | ESKDSHE. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4V438N. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reactome | REACT_116125. Disease. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bgee | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_PSIP1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000164985. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR021567. LEDGF. IPR000313. PWWP. IPR017859. Treacle-like_TCS. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF11467. LEDGF. 1 hit. PF00855. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRINTS | PR01503. TREACLE. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00293. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS50812. PWWP. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | PSIP1. human. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 11168. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NextBio | 42491. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | O75475. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | PSIP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O75475 Secondary accession number(s): D3DRI9 Q9UER6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
